First-line treatment of advanced non-small-cell lung cancer (NSCLC) with vinorelbine and cisplatin.

被引：0
|
作者：
Bobilev, D [1 ]
Ariad, S [1 ]
Geffen, DB [1 ]
Cohen, Y [1 ]
机构：
[1] Soroka Univ, Med Ctr, Beer Sheva, Israel
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
539P
引用
下载
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates
    Provencio, M.
    Blanco, R.
    Alberola, V.
    Delgado, J. R.
    Diz, P.
    Almenarez, J. A.
    Lopez-Vivanco, G.
    Gonzalez-Larriba, J. L.
    Martin, G.
    Rosell, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 384 - 384
  • [2] Cisplatin plus vinorelbine as first-line treatment for advanced non-small-cell lung cancer: Is a hemogram on day 8 essential?
    Provencio, Mariano
    de Las Penas, Ramon
    Camps, Carlos
    Artal, Angel
    Massuti, Bartomeu
    Cobo, Manuel
    Javier Perez, Francisco
    Sanchez, Antonio
    Rosell, Rafael
    LUNG CANCER, 2010, 68 (03) : 415 - 419
  • [3] First-line treatment for advanced non-small-cell lung cancer
    Laskin, Janessa J.
    Sandler, Alan B.
    ONCOLOGY-NEW YORK, 2005, 19 (13): : 1671 - 1676
  • [4] Oral vinorelbine as single-agent first-line treatment in elderly patients (pts) with advanced non-small-cell lung cancer (NSCLC)
    Mendez, M.
    Andrade, J.
    Esquerdo, G.
    Morales, S.
    Garcia-Gomez, R.
    Garcia-Bueno, J. M.
    Blancas, I.
    Trujillo, R.
    Juarez, J. I.
    Gayo, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 389 - 389
  • [5] Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
    Dediu, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1345 - 1347
  • [6] First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with ImmuneCheckpoint Inhibitors
    Bylicki, Olivier
    Barazzutti, Helene
    Paleiron, Nicolas
    Margery, Jacques
    Assie, Jean-Baptiste
    Chouaid, Christos
    BIODRUGS, 2019, 33 (02) : 159 - 171
  • [7] Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Molecular correlates
    de las Penas, R.
    Provencio, M.
    Camps, C.
    Cobo, M.
    Massuti, B.
    Jimenez, U.
    Artal, A.
    Cardenal, F.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Farhat, Fadi S.
    Ghosn, Marwan G.
    Kattan, Joseph G.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 235 - 242
  • [9] Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
    Fadi S. Farhat
    Marwan G. Ghosn
    Joseph G. Kattan
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 235 - 242
  • [10] Vinorelbine (VRL) plus gemcitabine (GEM) as first-line treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates
    Maestu, I.
    Isla, D.
    Pedraza, M.
    Munoz, J.
    Oramas, J.
    Garcia-Gomez, R.
    del Barco, S.
    Cantos, B.
    Taron, M.
    Rosell, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 384 - 385
12345